AXGN Axogen, Inc.
Nasdaq · SEC CIK 805928 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $19.88M 31 sales by 12 insiders
- Filings on record
- 236 since 2021-07-21, latest 2026-09-04 16:08
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Began Marc A | EVP, GC | — | $3.88M |
| Burke William P. Mr. | Dir | — | $2.82M |
| Weiler Kathy Johnson | Dir | — | $2.74M |
| DALE MICHAEL D | CEO | — | $2.67M |
| Wendell Amy McBride | Dir | — | $2.00M |
| JOHNSON JOHN | Dir | — | $1.87M |
| TYNDALL JOSEPH A. | Dir | — | $951.8K |
| Hartley Lindsey Marie | CFO | — | $942.2K |
| DeVinney Erick Wayne | Chief Innovation Off | — | $780.6K |
| THOMAS PAUL | Dir | — | $633.6K |
Transactions 312
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-21 | 2021-07-19 | AXGN | MARIANI PETER J | EVP, CFO | A - Grant | $0.00 | +3,710 | 21.9K | +20% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | MARIANI PETER J | EVP, CFO | F - Tax | $19.20 | -918 | 21.0K | -4% | -$17.6K | |
| 2021-07-21 | 2021-07-20 | AXGN | Scopelianos Angelo | Chief R, D Off | F - Tax | $19.20 | -637 | 10.1K | -6% | -$12.2K | |
| 2021-07-21 | 2021-07-19 | AXGN | Scopelianos Angelo | Chief R, D Off | A - Grant | $0.00 | +2,572 | 10.8K | +31% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | Sandberg Eric | Chief Commercial Off | F - Tax | $19.20 | -1,090 | 6,541 | -14% | -$20.9K | |
| 2021-07-21 | 2021-07-19 | AXGN | Sandberg Eric | Chief Commercial Off | A - Grant | $0.00 | +4,408 | 7,631 | +137% | $0 | |
| 2021-07-21 | 2021-07-19 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,580 | 80.8K | +2% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $19.20 | -392 | 80.4K | -0.5% | -$7,526 | |
| 2021-07-21 | 2021-07-19 | AXGN | Zaderej Karen L. | CEO, Dir | A - Grant | $0.00 | +22.1K | 788.8K | +3% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | Zaderej Karen L. | CEO, Dir | F - Tax | $19.20 | -8,812 | 780.0K | -1% | -$169.2K | |
| 2021-07-21 | 2021-07-19 | AXGN | Donovan Michael Patrick | VP Ops | A - Grant | $0.00 | +2,572 | 43.4K | +6% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | Donovan Michael Patrick | VP Ops | F - Tax | $19.20 | -637 | 42.8K | -1% | -$12.2K |
Purchase Sale Sale after option exercise All abbreviations